T1	And 162 166	with
E1	And:T1 Arg:T46 Arg2:E2
T2	Condition 167 196	immune mediated enteropathies
E2	Condition:T2 Name:T47
T3	And 197 200	who
E3	And:T3 Arg:E2 Arg2:E4
T4	Assertion 210 233	improvement in symptoms
E4	Assertion:T4 
A1	Assertion-Type-Value E4 hypothetical
T5	Or 234 237	and
E5	Or:T5 Arg:E4 Arg2:E6
T6	Procedure 238 247	histology
E6	Procedure:T6 Name:T77
T7	Eq-Comparison 248 250	on
E7	Eq-Comparison:T7 Temporal-Period:T78
T8	Procedure 251 274	oral budesonide therapy
E8	Procedure:T8 Name:T48 Temporality:E7
T9	Age 300 303	Age
E9	Age:T9 Eq-Comparison:E10
T10	Eq-Comparison 304 313	<18 years
E10	Eq-Comparison:T10 Operator:T49 Value:T50 Temporal-Unit:T51
T11	Observation 328 348	stool gluten testing
E11	Observation:T11 Name:T53 Polarity:T52
T12	Condition 366 391	refractory celiac disease
E12	Condition:T12 Name:T54
T13	Condition 397 419	Small bowel malignancy
E13	Condition:T13 Name:T55
T14	Or 420 422	or
E14	Or:T14 Arg:E13 Arg2:E16
T15	Eq-Comparison 423 430	history
E15	Eq-Comparison:T15 Temporal-Period:T56
T16	Condition 434 456	small bowel malignancy
E16	Condition:T16 Name:T57 Temporality:E15
T17	Condition 462 487	Refractory celiac disease
E17	Condition:T17 Name:T58
T20	Condition 516 544	lymphoproliferative disorder
E20	Condition:T20 Name:T61
T21	Condition 556 567	enteropathy
E21	Condition:T21 Name:T62
T22	Negation 573 575	No
E22	Negation:T22 
T23	Eq-Comparison 576 581	prior
E23	Eq-Comparison:T23 Temporal-Period:T63
T24	Assertion 582 605	improvement in symptoms
E24	Assertion:T24 
A2	Assertion-Type-Value E24 hypothetical
T25	Or 606 609	and
E25	Or:T25 Arg:E24 Arg2:E26
T26	Procedure 610 619	histology
E26	Procedure:T26 Name:T80 Temporality:E23
T27	Procedure 625 643	budesonide therapy
E27	Procedure:T27 Name:T64
T28	Procedure 668 686	budesonide therapy
E28	Procedure:T28 Name:T65
T29	Temporal-Connection 687 695	prior to
E29	Temporal-Connection:T29 Arg:E28 Arg2:E30
A3	Temporal-Connection-Type-Value E29 before
T30	Study 700 705	trial
E30	Study:T30 
T31	Other 711 716	Other
E31	Other:T31 Is-Other:E33
T32	Modifier 717 736	concurrent systemic
E32	Modifier:T32 Modifies:T66
T33	Drug 737 752	corticosteroids
E33	Drug:T33 Name:T66
T34	Other 758 763	Other
E34	Other:T34 Is-Other:E35
T35	Drug 764 792	immune mediating medications
E35	Drug:T35 Name:T67
T37	Drug 825 837	azathioprine
E37	Drug:T37 Name:T68
T45	Location 112 140	Mayo Clinic in Rochester, MN
A4	Location-Value T45 hospital
T46	Life-Stage-And-Gender 147 152	Adult
A5	Life-Stage-And-Gender-Type T46 adult
T47	Condition-Name 167 196	immune mediated enteropathies
T48	Procedure-Name 251 274	oral budesonide therapy
T49	Eq-Operator 304 305	<
A6	Eq-Operator-Value T49 LT
T50	Eq-Value 305 307	18
T51	Eq-Temporal-Unit 308 313	years
A7	Eq-Temporal-Unit-Value T51 year
T52	Polarity 319 327	Positive
A8	Polarity-Value T52 positive
T53	Observation-Name 328 348	stool gluten testing
A9	Observation-Type-Value T53 lab
T54	Condition-Name 366 391	refractory celiac disease
T55	Condition-Name 397 419	Small bowel malignancy
T56	Eq-Temporal-Period 423 430	history
A10	Eq-Temporal-Period-Value T56 past
T57	Condition-Name 434 456	small bowel malignancy
T58	Condition-Name 462 487	Refractory celiac disease
T60	Procedure-Name 505 515	transplant
T61	Condition-Name 516 544	lymphoproliferative disorder
T62	Condition-Name 556 567	enteropathy
T63	Eq-Temporal-Period 576 581	prior
A11	Eq-Temporal-Period-Value T63 past
T64	Procedure-Name 625 643	budesonide therapy
T65	Procedure-Name 668 686	budesonide therapy
T66	Drug-Name 737 752	corticosteroids
T67	Drug-Name 764 792	immune mediating medications
T68	Drug-Name 825 837	azathioprine
T76	Location 60 103	Division of Gastroenterology and Hepatology
A12	Location-Value T76 clinic
T77	Procedure-Name 238 247	histology
T78	Eq-Temporal-Period 248 250	on
A13	Eq-Temporal-Period-Value T78 present
T79	And 361 365	with
E45	And:T79 Arg:E11 Arg2:E12
T18	Modifier 488 494	type 2
E18	Modifier:T18 Modifies:T58
T19	Procedure 505 515	transplant
E19	Procedure:T19 Name:T60
T59	Temporal-Connection 500 504	Post
E46	Temporal-Connection:T59 Arg:E19 Arg2:E20
A14	Temporal-Connection-Type-Value E46 after
R1	Caused-By Arg1:E21 Arg2:E20	
T80	Procedure-Name 610 619	histology
R2	Abbrev-Of Arg1:E22 Arg2:E26	
T81	And 620 624	with
E47	And:T81 Arg:E26 Arg2:E27
T82	Negation 649 664	Discontinuation
E48	Negation:T82 Negates:E28
T36	Drug 839 855	6-mercaptopurine
E36	Drug:T36 Name:T38
T38	Drug-Name 839 855	6-mercaptopurine
T39	Drug 857 869	cyclosporine
E38	Drug:T39 Name:T40
T40	Drug-Name 857 869	cyclosporine
T41	Drug 871 883	methotrexate
E39	Drug:T41 Name:T42
T42	Drug-Name 871 883	methotrexate
T43	Drug 885 915	anti-TNF monoclonal antibodies
E40	Drug:T43 Name:T44
T44	Drug-Name 885 915	anti-TNF monoclonal antibodies
T69	Drug 917 971	alpha-4 beta-7 integrin inhibiting monoclonal antibody
E41	Drug:T69 Name:T70
T70	Drug-Name 917 971	alpha-4 beta-7 integrin inhibiting monoclonal antibody
T71	Drug 973 1021	interleukin 12/23 inhibiting monoclonal antibody
E42	Drug:T71 Name:T72
T72	Drug-Name 973 1021	interleukin 12/23 inhibiting monoclonal antibody
T73	Drug 1023 1037	JAK inhibitors
E43	Drug:T73 Name:T74
T74	Drug-Name 1023 1037	JAK inhibitors
R3	Example-Of Arg1:E37 Arg2:E35	
R4	Example-Of Arg1:E36 Arg2:E35	
R5	Example-Of Arg1:E38 Arg2:E35	
R6	Example-Of Arg1:E39 Arg2:E35	
R7	Example-Of Arg1:E40 Arg2:E35	
R8	Example-Of Arg1:E41 Arg2:E35	
R9	Example-Of Arg1:E42 Arg2:E35	
R10	Example-Of Arg1:E43 Arg2:E35	
